Dementia
Disease State Hub
Featured
10/28/2024
Miranda Manier, BA
A study found several neuropsychiatric symptoms in patients with Alzheimer disease, such as aggression, anxiety, and disinhibition, were significantly associated with worsening functional abilities.
10/28/2024
10/10/2024
Miranda Manier, BA
A cluster-randomized controlled trial examined the impact of personalized music on reducing agitation in nursing home residents with dementia, revealing significant reductions in verbally agitated behaviors...
10/10/2024
09/25/2024
Anthony Calabro, MA
Researchers analyzed patient data from the Alzheimer’s Disease in Down Syndrome study to determine the sex differences in Alzheimer-related neuropsychiatric symptomology among adults with Down syndrome. ...
09/25/2024
Interactive Features
02/22/2024
In their presentation at the Practical Updates in Primary Care 2023 Virtual Series, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C reviewed the pathophysiological mechanisms of agitation...
02/22/2024
12/02/2023
Your patient is a 46-year-old woman with a family history of dementia and obesity. Based on her family history, she asks you if there is a way to reduce her risk of developing dementia, and a way to stay...
12/02/2023
11/11/2023
Increasing age is a risk factor for Alzheimer dementia (AD), and as the US population grows older and lives longer, new and existing cases of AD are projected to rise as well. How many older Americans are...
11/11/2023
04/16/2023
Your patient is a 56-year-old woman with a family history of dementia. She asks you if her coffee intake would increase her risk of being diagnosed with dementia in the future.
04/16/2023
01/20/2020
Many patients with Alzheimer disease may become confused, anxious, aggressive, agitated, or restless consistently in the late afternoon or early evening. Do you know when this symptom, known as sundowning,...
01/20/2020
Clinical Insights
08/29/2024
In this video, Kasia Rothenberg, MD, PhD, describes Alzheimer disease-related agitation, details the difficulty in testing for Alzheimer disease-related agitation, looks ahead to potential treatment options...
08/29/2024
04/19/2024
In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C provide the take-home messages from their session “Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem” at our...
04/19/2024
04/14/2024
Samar R. El Khoudary, PhD, MPH, BPharm, FAHA
In a long-term follow-up study, Samar R. El Khoudary, PhD, MPH, BPharm, FAHA, and colleagues investigated how the quantity and quality of cardiovascular fat in women with Alzheimer disease measured during...
04/14/2024
03/25/2024
Brenden P. Lucy, MD
In a small clinical trial, researchers found that patients taking suvorexant, an FDA-approved treatment for insomnia, had reduced levels of amyloid beta (amyloid-β) and tau phosphorylation proteins, which...
03/25/2024
